Cervical Cancer Profile in dr. Cipto Mangunkusumo Hospital Year 2013

Soehartati Argadikoesoema Gondhowiardjo; Adji Kusumadjati; Prasetya Wibisono; Sri Mutya Sekarutami

doi:10.32532/jori.v10i1.99

Cervical Cancer Profile in dr. Cipto Mangunkusumo Hospital Year 2013

Soehartati Argadikoesoema Gondhowiardjo, Adji Kusumadjati, Prasetya Wibisono, Sri Mutya Sekarutami

Sari

Background: Cervical cancer ranks in the second place based on the malignancy among female sex in Indonesia with a prevalence of 14.4% and a mortality rate of 10.3%. Hospital-Based Cancer Registry (HBCR) is a system of cancer registration in a hospital that can provide information about the general information of cancer patients, treatment, and outcome of treatment. This study was conducted to obtain the profile of cervical cancer in dr. Cipto Mangunkusumo general hospital (RSCM) in 2013 based on data from HBCR RSCM.

Methods: The study was conducted by extracting the epidemiological data and cervical tumor data from HBCR RSCM in 2013 which was then analyzed descriptively.

Results: The result showed that cervical cancer ranks at the second place from all the malignancy at RSCM (12%, n= 678), with domicile mostly come from outside Jakarta (52.8%, n = 358). The average age of cervical cancer was 49.48 years, the most common occurs in the age range 45-49 years. In terms of histopathology, squamous cell carcinoma is the most prevalent type of histopathology (74.2%, n = 447). The surgery is a type of action that done for early-stage cervical cancer (83,3%, n = 25), whereas the action of radiation is mostly done in locally advanced cervical cancer (79,9%, n = 273).

Conclusion: Nevertheless, cervical cancer has a significant health burden in Dr. Cipto Mangunkusumo general hospital which is needed further management.

Kata Kunci

cervical cancer; hospital-based cancer registry

Teks Lengkap:

PDF (English)

Referensi

Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar 2013. Riset Kesehatan Dasar 2013;

WHO. International Agency for Research on Cancer, Globocan [Internet]. 2012 [cited 2015 Sep 10];Available from: http://globocan.iarc.fr

Akila N. Viswanathan. Uterine Cervix. In: Edward C. Halperin, MD M, David E. Wazer, MD F, Carlos A. Perez M, Luther W. Brady M, editors. Perez and Brady’s Principles and Practice of radiation oncology. Philadelphia: LIPPINCOTT WILLIAMS & WILKINS; 2013. p. 1355–426.

Nina A. Mayr WSJ, Ney and DKG. Cervical Cancer. In: L.W. Brady P, H.-P. Heilmann H, M. Molls M, C. Nieder B, editors. Decision Making in Radiation Oncology, Volume 2. New York: Springer; 2011. p. 661–702.

Kementerian Kesehatan Republik Indonesia [Internet]. [cited 2016 Mar 29];Available from: http://www.depkes.go.id/article/view/15020400003/menkes-canangkankomitmen-penanggulangan-kanker-di-indonesia.html

Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol [Internet] 2000 [cited 2016 May 23];18(8):1606–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10764420

Rose PG, Ali S, Watkins E, et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007.

KPKN. Pedoman Nasional Pelayanan Kedokteran (PNPK) Kanker Serviks. Jakarta: Kementerian Kesehatan RI; 2016.

Hospital based cancer registry [Internet]. [cited 2016 Apr 6]; Available from: http://www.hbcrindia.org/About_HBCR.aspx

Murat Beyzadeoglu, Cuneyt Ebruli and GO. Gynecological cancers. In: Murat Beyzadeoglu, Cuneyt Ebruli and GO, editor. Basic Radiation Oncology. New York: Springer; 2010. p. 411–32.

Jhingran A, Russell AH, Seiden M V, et al. Cancers of the Cervix , Vulva , and Vagina [Internet]. Fifth Edit. Elsevier Inc.; 2016. Available from: http://dx.doi.org/10.1016/B978-1-4557-2865-7.00087-4.

Ann Barrett, Jane Dobbs SM and TR. Principles of Brachytherapy. In: Ann Barrett, Jane Dobbs SM and TR, editor. Practical Radiotherapy Planning. London: Hodder Arnold; 2009. p. 53–61.

Beriwal S, Bhatnagar A, Heron DE, et al. High-dose-rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy [Internet] [cited 2016 Mar 1];5(4):218–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17118313

Indonesian Society of Gynecologic Oncologic. National Data 2013 [Internet]. 2013 [cited 2016 Dec 2];Available from: inasgo.org

De Almeida FM, de Oliveira JC, Martins E, Curado MP, de Freitas R, Moreira MAR. Monitoring the profile of cervical cancer in a developing city. BMC Public Health [Internet] 2013;13:563. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3691764&tool= pmcentrez&rendertype=abstract

Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health 2015;7:405–14.

Shi J-F, Qiao Y-L, Smith JS, et al. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine [Internet] 2008;26 Suppl 1(2008):M53-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18945414

Federico C, Alleyn J, Dola C, et al. Relationship among age, race, medical funding, and cervical cancer survival. J Natl Med Assoc [Internet] 2010;102(3):199–205. Available from: http://dx.doi.org/10.1016/S0027- 9684(15)30526-5

Sapp H, Goetzl L, Creasman W, Kohler M, Underwood P, Esnaola N. Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol 2008;199(2):1–7.

Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol [Internet] 1998 [cited 2016 Dec 6];71(2):151–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9826453

Monk BJ, Tian C, Rose PG, Lanciano R. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecol Oncol [Internet] 2007 [cited 2016 Dec 6];105(2):427–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17275889

Robinson J. Cervical cancer: occupational risks. Lancet (London, England) [Internet] [cited 2016 Dec 6];2(8365–66):1496–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6140582

Weiderpass E, Pukkala E, Vasama-Neuvonen K, et al. Occupational exposures and cancers of the endometrium and cervix uteri in Finland. Am J Ind Med [Internet] 2001 [cited 2016 Dec 6];39(6):572–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11385641

Wiebe E, Denny L, Thomas G. International Journal of Gynecology and Obstetrics Cancer of the cervix uteri. Int J Gynecol Obs 2012;2:100–9.

Vinh-Hung V, Bourgain C, Vlastos G, et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer [Internet] 2007 [cited 2016 Dec 7];7(1):164. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17718897

Monk BJ, Wang J, Im S, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol [Internet] 2005 [cited 2016 Dec 7];96(3):721–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15721417

Puri S, Ashat M, Pandey a, Goel NK, Singh a, Kaushal V. Sociodemographic characteristics of cancer patients: hospital based cancer registry in a tertiary care hospital of India. Indian J Cancer [Internet] 2014;51(1):1–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24947086

Wui-jin Koh et all. Cervical Cancer. National Comprehensive Cancer Network Guidelines; 2016

DOI: https://doi.org/10.32532/jori.v10i1.99 <